Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hemophilia A | 49 | 2014 | 56 | 2.610 |
Why?
|
Factor VIII | 23 | 2014 | 31 | 1.190 |
Why?
|
HIV Seropositivity | 17 | 1995 | 82 | 0.520 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2015 | 12 | 0.490 |
Why?
|
Acquired Immunodeficiency Syndrome | 11 | 1996 | 137 | 0.370 |
Why?
|
Blood Coagulation Factors | 4 | 1996 | 13 | 0.340 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 39 | 0.300 |
Why?
|
Hodgkin Disease | 1 | 2008 | 55 | 0.300 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2008 | 193 | 0.280 |
Why?
|
Leukocyte Count | 9 | 2015 | 97 | 0.250 |
Why?
|
HIV | 6 | 1998 | 68 | 0.240 |
Why?
|
Isoantibodies | 2 | 1996 | 33 | 0.230 |
Why?
|
Hepatitis C | 6 | 1995 | 143 | 0.220 |
Why?
|
HIV-1 | 8 | 1999 | 692 | 0.210 |
Why?
|
Sexual Behavior | 2 | 1992 | 189 | 0.180 |
Why?
|
Humans | 67 | 2015 | 59106 | 0.180 |
Why?
|
HIV Infections | 10 | 1999 | 912 | 0.180 |
Why?
|
Recombinant Fusion Proteins | 2 | 2011 | 488 | 0.160 |
Why?
|
Male | 36 | 2015 | 27623 | 0.160 |
Why?
|
Genetic Therapy | 2 | 2005 | 733 | 0.160 |
Why?
|
Transfusion Reaction | 4 | 1992 | 44 | 0.150 |
Why?
|
Home Infusion Therapy | 2 | 2001 | 7 | 0.150 |
Why?
|
Immunoglobulin G | 3 | 2014 | 444 | 0.150 |
Why?
|
Surgical Procedures, Operative | 2 | 1996 | 137 | 0.150 |
Why?
|
Professional Staff Committees | 1 | 1997 | 5 | 0.140 |
Why?
|
HIV Antibodies | 4 | 1994 | 133 | 0.140 |
Why?
|
Malaria Vaccines | 1 | 1997 | 27 | 0.140 |
Why?
|
Hemorrhage | 3 | 2001 | 258 | 0.140 |
Why?
|
Vaccines, Synthetic | 1 | 1997 | 67 | 0.140 |
Why?
|
Clinical Trials as Topic | 3 | 1997 | 441 | 0.130 |
Why?
|
Factor IX | 5 | 2000 | 7 | 0.130 |
Why?
|
Child, Preschool | 13 | 2001 | 1779 | 0.130 |
Why?
|
Hemostasis | 1 | 1996 | 18 | 0.130 |
Why?
|
Anterior Cruciate Ligament | 1 | 1995 | 13 | 0.120 |
Why?
|
Leukapheresis | 1 | 2015 | 8 | 0.120 |
Why?
|
Zidovudine | 2 | 1994 | 12 | 0.120 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2015 | 11 | 0.120 |
Why?
|
Diverticulitis | 1 | 2015 | 28 | 0.120 |
Why?
|
Cysts | 1 | 1995 | 40 | 0.120 |
Why?
|
Adult | 29 | 2015 | 15615 | 0.120 |
Why?
|
Autoantibodies | 2 | 2014 | 171 | 0.120 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 2014 | 8 | 0.120 |
Why?
|
Arthroplasty | 1 | 1994 | 4 | 0.120 |
Why?
|
Child | 19 | 2001 | 4168 | 0.120 |
Why?
|
Hepatitis Antibodies | 3 | 1992 | 6 | 0.120 |
Why?
|
Sexual Partners | 3 | 1991 | 75 | 0.120 |
Why?
|
Menisci, Tibial | 1 | 1994 | 24 | 0.120 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 67 | 0.120 |
Why?
|
Spectrometry, Fluorescence | 1 | 2014 | 90 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2011 | 19 | 0.110 |
Why?
|
T-Lymphocytes, Cytotoxic | 6 | 1999 | 168 | 0.110 |
Why?
|
Hemophilia B | 3 | 1996 | 4 | 0.110 |
Why?
|
Hepatitis, Viral, Human | 2 | 1990 | 10 | 0.110 |
Why?
|
Immune Tolerance | 3 | 1993 | 172 | 0.110 |
Why?
|
Immunophenotyping | 3 | 2009 | 184 | 0.100 |
Why?
|
Comprehensive Health Care | 1 | 1993 | 17 | 0.100 |
Why?
|
Adolescent | 16 | 2014 | 5816 | 0.100 |
Why?
|
T-Lymphocyte Subsets | 1 | 1994 | 244 | 0.100 |
Why?
|
Knee Joint | 3 | 1995 | 285 | 0.100 |
Why?
|
Repressor Proteins | 2 | 2011 | 332 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2011 | 15 | 0.090 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2011 | 13 | 0.090 |
Why?
|
Hypersensitivity, Delayed | 3 | 1987 | 19 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2015 | 5101 | 0.090 |
Why?
|
Growth Disorders | 1 | 1990 | 28 | 0.090 |
Why?
|
Antigens | 2 | 1996 | 146 | 0.080 |
Why?
|
Leukemia, Myeloid, Chronic-Phase | 1 | 2009 | 5 | 0.080 |
Why?
|
Basophils | 1 | 2009 | 14 | 0.080 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2008 | 5 | 0.080 |
Why?
|
Postoperative Complications | 1 | 1995 | 1184 | 0.080 |
Why?
|
Family Planning Services | 1 | 1988 | 21 | 0.080 |
Why?
|
Antibodies | 1 | 1989 | 179 | 0.080 |
Why?
|
Immune System | 1 | 1989 | 129 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2008 | 214 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 1992 | 444 | 0.070 |
Why?
|
Aged | 11 | 2008 | 13348 | 0.070 |
Why?
|
Antibodies, Monoclonal | 3 | 1992 | 836 | 0.070 |
Why?
|
Middle Aged | 16 | 2011 | 16240 | 0.060 |
Why?
|
Infant | 7 | 2001 | 1482 | 0.060 |
Why?
|
Hemarthrosis | 1 | 1985 | 3 | 0.060 |
Why?
|
Antibody Formation | 3 | 2000 | 108 | 0.060 |
Why?
|
Joint Diseases | 1 | 1985 | 18 | 0.060 |
Why?
|
HIV Seronegativity | 2 | 1994 | 18 | 0.060 |
Why?
|
Genes, nef | 2 | 1995 | 6 | 0.060 |
Why?
|
Recombinant Proteins | 6 | 2000 | 688 | 0.060 |
Why?
|
Polymerase Chain Reaction | 5 | 1999 | 495 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 4 | 1991 | 109 | 0.050 |
Why?
|
Risk Factors | 6 | 2001 | 4948 | 0.050 |
Why?
|
Age Factors | 1 | 2005 | 1499 | 0.050 |
Why?
|
Multicenter Studies as Topic | 3 | 1991 | 130 | 0.050 |
Why?
|
Pregnancy | 3 | 2015 | 2202 | 0.040 |
Why?
|
Antibodies, Viral | 4 | 1987 | 291 | 0.040 |
Why?
|
Female | 11 | 2015 | 30613 | 0.040 |
Why?
|
HIV Long-Term Survivors | 1 | 1999 | 8 | 0.040 |
Why?
|
Prospective Studies | 7 | 1996 | 3052 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 1994 | 2330 | 0.040 |
Why?
|
Cohort Studies | 5 | 2001 | 2367 | 0.040 |
Why?
|
Wounds, Gunshot | 1 | 1979 | 51 | 0.040 |
Why?
|
Gene Products, gag | 3 | 1997 | 63 | 0.040 |
Why?
|
Time Factors | 3 | 2014 | 3586 | 0.040 |
Why?
|
Risk Assessment | 1 | 2005 | 1898 | 0.040 |
Why?
|
DNA, Viral | 3 | 1995 | 223 | 0.040 |
Why?
|
Hypohidrosis | 1 | 1998 | 3 | 0.040 |
Why?
|
Lymphoma, T-Cell | 1 | 1998 | 22 | 0.040 |
Why?
|
Alopecia | 1 | 1998 | 25 | 0.040 |
Why?
|
Sweat Gland Neoplasms | 1 | 1998 | 20 | 0.040 |
Why?
|
Pruritus | 1 | 1998 | 29 | 0.040 |
Why?
|
Sjogren's Syndrome | 1 | 1998 | 24 | 0.040 |
Why?
|
Fractures, Bone | 1 | 1979 | 135 | 0.040 |
Why?
|
Semen | 1 | 1998 | 42 | 0.040 |
Why?
|
Leukocytes | 1 | 1998 | 97 | 0.040 |
Why?
|
Blood Transfusion | 4 | 1992 | 149 | 0.030 |
Why?
|
T-Lymphocytes | 3 | 1999 | 982 | 0.030 |
Why?
|
Lymphoma, AIDS-Related | 1 | 1996 | 7 | 0.030 |
Why?
|
Desensitization, Immunologic | 1 | 1996 | 9 | 0.030 |
Why?
|
Contraindications | 1 | 1996 | 44 | 0.030 |
Why?
|
Global Health | 2 | 1995 | 167 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1996 | 50 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2005 | 5227 | 0.030 |
Why?
|
Immunization | 1 | 1996 | 127 | 0.030 |
Why?
|
Anaphylaxis | 1 | 1996 | 40 | 0.030 |
Why?
|
Martial Arts | 1 | 1995 | 1 | 0.030 |
Why?
|
Patella | 1 | 1995 | 13 | 0.030 |
Why?
|
Factor VII | 2 | 1992 | 3 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 1994 | 620 | 0.030 |
Why?
|
Species Specificity | 1 | 1996 | 328 | 0.030 |
Why?
|
Tendons | 1 | 1995 | 23 | 0.030 |
Why?
|
Bone Transplantation | 1 | 1995 | 24 | 0.030 |
Why?
|
Live Birth | 1 | 2015 | 20 | 0.030 |
Why?
|
Pulmonary Ventilation | 1 | 2015 | 37 | 0.030 |
Why?
|
Anterior Cruciate Ligament Injuries | 1 | 1995 | 26 | 0.030 |
Why?
|
Bone Resorption | 1 | 1995 | 41 | 0.030 |
Why?
|
Swine | 1 | 1996 | 350 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 1995 | 119 | 0.030 |
Why?
|
Reference Values | 2 | 1992 | 326 | 0.030 |
Why?
|
HIV Antigens | 2 | 1991 | 18 | 0.030 |
Why?
|
HIV Core Protein p24 | 2 | 1991 | 17 | 0.030 |
Why?
|
Tibia | 1 | 1995 | 68 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 1994 | 22 | 0.030 |
Why?
|
Knee Injuries | 1 | 1995 | 47 | 0.030 |
Why?
|
Arthroscopy | 1 | 1994 | 24 | 0.030 |
Why?
|
Patient Selection | 1 | 1997 | 458 | 0.030 |
Why?
|
von Willebrand Diseases | 2 | 1992 | 4 | 0.030 |
Why?
|
Dyspnea | 1 | 2015 | 116 | 0.030 |
Why?
|
Osteotomy | 1 | 1994 | 14 | 0.030 |
Why?
|
Blotting, Western | 2 | 1992 | 582 | 0.030 |
Why?
|
Cesarean Section | 1 | 2015 | 95 | 0.030 |
Why?
|
Terminology as Topic | 1 | 1994 | 129 | 0.030 |
Why?
|
Hospitalization | 1 | 2001 | 1288 | 0.030 |
Why?
|
Gene Deletion | 1 | 1995 | 292 | 0.030 |
Why?
|
Radiography | 1 | 1995 | 515 | 0.030 |
Why?
|
Lymphocyte Activation | 3 | 1999 | 743 | 0.030 |
Why?
|
Hepatitis B | 3 | 1992 | 28 | 0.030 |
Why?
|
Blood Donors | 2 | 1990 | 22 | 0.030 |
Why?
|
Drug Contamination | 2 | 1990 | 15 | 0.030 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 1991 | 105 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 1998 | 403 | 0.030 |
Why?
|
Gene Products, nef | 1 | 1992 | 13 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 1992 | 36 | 0.030 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 1992 | 24 | 0.030 |
Why?
|
CD4 Antigens | 2 | 1991 | 148 | 0.030 |
Why?
|
Prevalence | 3 | 1992 | 1250 | 0.030 |
Why?
|
Factor VII Deficiency | 1 | 1992 | 1 | 0.020 |
Why?
|
Factor VIIIa | 1 | 1992 | 1 | 0.020 |
Why?
|
Factor IXa | 1 | 1992 | 1 | 0.020 |
Why?
|
Factor X | 1 | 1992 | 2 | 0.020 |
Why?
|
Prothrombin | 1 | 1992 | 3 | 0.020 |
Why?
|
Factor VIIa | 1 | 1992 | 3 | 0.020 |
Why?
|
Skin Tests | 3 | 1986 | 21 | 0.020 |
Why?
|
Prenatal Diagnosis | 2 | 1992 | 38 | 0.020 |
Why?
|
Blood Coagulation | 1 | 1992 | 37 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 1022 | 0.020 |
Why?
|
AIDS-Related Complex | 1 | 1991 | 3 | 0.020 |
Why?
|
Imatinib Mesylate | 1 | 2011 | 33 | 0.020 |
Why?
|
Placebos | 1 | 1991 | 68 | 0.020 |
Why?
|
Herpesviridae Infections | 3 | 1986 | 25 | 0.020 |
Why?
|
Benzamides | 1 | 2011 | 63 | 0.020 |
Why?
|
Piperazines | 1 | 2011 | 74 | 0.020 |
Why?
|
HTLV-I Antibodies | 1 | 1990 | 2 | 0.020 |
Why?
|
Virus Diseases | 1 | 1992 | 114 | 0.020 |
Why?
|
Immunologic Techniques | 1 | 1990 | 12 | 0.020 |
Why?
|
Growth | 1 | 1990 | 22 | 0.020 |
Why?
|
Pedigree | 1 | 1991 | 183 | 0.020 |
Why?
|
Virus Replication | 3 | 1999 | 304 | 0.020 |
Why?
|
Pyrimidines | 1 | 2011 | 129 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 1987 | 207 | 0.020 |
Why?
|
Prognosis | 1 | 2014 | 1593 | 0.020 |
Why?
|
Risk | 2 | 1988 | 364 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 1991 | 181 | 0.020 |
Why?
|
Viral Proteins | 1 | 1991 | 252 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1991 | 168 | 0.020 |
Why?
|
Immunity, Cellular | 2 | 1989 | 169 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2009 | 9 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2009 | 8 | 0.020 |
Why?
|
Biomarkers | 1 | 2014 | 1304 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 1989 | 50 | 0.020 |
Why?
|
Half-Life | 1 | 1989 | 74 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2009 | 38 | 0.020 |
Why?
|
Herpesvirus 4, Human | 3 | 1986 | 178 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2009 | 63 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 1989 | 86 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2009 | 152 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 2 | 1999 | 90 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1989 | 135 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 1991 | 277 | 0.020 |
Why?
|
CD8 Antigens | 3 | 1994 | 53 | 0.020 |
Why?
|
Deltaretrovirus | 2 | 1986 | 2 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 231 | 0.020 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1989 | 132 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1988 | 216 | 0.020 |
Why?
|
New England | 1 | 1988 | 262 | 0.020 |
Why?
|
Dermatitis, Contact | 1 | 1987 | 12 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2009 | 638 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 1988 | 91 | 0.020 |
Why?
|
Cytomegalovirus | 2 | 1986 | 90 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 1988 | 741 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 629 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2009 | 605 | 0.020 |
Why?
|
Hepatitis B Antigens | 1 | 1985 | 5 | 0.020 |
Why?
|
Animals | 2 | 1996 | 19589 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 4250 | 0.010 |
Why?
|
Motion | 1 | 1985 | 56 | 0.010 |
Why?
|
Long-Term Care | 1 | 1985 | 176 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1987 | 1189 | 0.010 |
Why?
|
Cytomegalovirus Infections | 3 | 1992 | 66 | 0.010 |
Why?
|
World Health Organization | 2 | 1995 | 30 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1998 | 1948 | 0.010 |
Why?
|
Virus Cultivation | 2 | 1994 | 17 | 0.010 |
Why?
|
Developing Countries | 2 | 1995 | 85 | 0.010 |
Why?
|
Receptors, Drug | 1 | 1982 | 5 | 0.010 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1982 | 18 | 0.010 |
Why?
|
Protein Kinase C | 1 | 1982 | 98 | 0.010 |
Why?
|
Antigens, Viral | 3 | 1987 | 129 | 0.010 |
Why?
|
Surveys and Questionnaires | 1 | 1988 | 2509 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 1991 | 29 | 0.010 |
Why?
|
Receptors, Chemokine | 1 | 1999 | 36 | 0.010 |
Why?
|
United States | 2 | 1990 | 7370 | 0.010 |
Why?
|
Population Surveillance | 1 | 2001 | 194 | 0.010 |
Why?
|
Neutrophils | 1 | 1982 | 353 | 0.010 |
Why?
|
Chemokines | 1 | 1999 | 92 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 185 | 0.010 |
Why?
|
Extremities | 1 | 1979 | 46 | 0.010 |
Why?
|
Viral Load | 1 | 1999 | 219 | 0.010 |
Why?
|
Disease Reservoirs | 1 | 1998 | 9 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1985 | 682 | 0.010 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 1982 | 397 | 0.010 |
Why?
|
HIV Protease Inhibitors | 1 | 1998 | 105 | 0.010 |
Why?
|
Phylogeny | 1 | 1998 | 336 | 0.010 |
Why?
|
RNA, Viral | 1 | 1998 | 259 | 0.010 |
Why?
|
HIV Protease | 1 | 1998 | 120 | 0.010 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1996 | 68 | 0.010 |
Why?
|
Genetic Variation | 1 | 1998 | 357 | 0.010 |
Why?
|
Mice | 1 | 1989 | 10247 | 0.010 |
Why?
|
Consumer Product Safety | 1 | 1995 | 12 | 0.010 |
Why?
|
Developed Countries | 1 | 1995 | 16 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 1552 | 0.010 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1994 | 26 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 1994 | 48 | 0.010 |
Why?
|
Viremia | 1 | 1994 | 44 | 0.010 |
Why?
|
Primary Prevention | 1 | 1995 | 134 | 0.010 |
Why?
|
Genes, gag | 1 | 1993 | 11 | 0.010 |
Why?
|
Formaldehyde | 1 | 1993 | 32 | 0.010 |
Why?
|
Histological Techniques | 1 | 1993 | 18 | 0.010 |
Why?
|
Safety | 1 | 1993 | 141 | 0.010 |
Why?
|
Base Sequence | 1 | 1995 | 1299 | 0.010 |
Why?
|
Genetic Carrier Screening | 1 | 1992 | 14 | 0.010 |
Why?
|
Genetic Counseling | 1 | 1992 | 15 | 0.010 |
Why?
|
Fetal Diseases | 1 | 1992 | 21 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1991 | 28 | 0.010 |
Why?
|
International Cooperation | 1 | 1992 | 84 | 0.010 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 1991 | 35 | 0.010 |
Why?
|
Viral Core Proteins | 1 | 1991 | 30 | 0.010 |
Why?
|
Protein Precursors | 1 | 1991 | 75 | 0.010 |
Why?
|
Hot Temperature | 1 | 1992 | 126 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1991 | 60 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1991 | 144 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1990 | 47 | 0.010 |
Why?
|
Hemostasis, Surgical | 1 | 1990 | 17 | 0.010 |
Why?
|
HTLV-I Infections | 1 | 1990 | 3 | 0.010 |
Why?
|
France | 1 | 1990 | 13 | 0.010 |
Why?
|
Blood Loss, Surgical | 1 | 1990 | 56 | 0.010 |
Why?
|
Clinical Enzyme Tests | 1 | 1990 | 12 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1990 | 38 | 0.010 |
Why?
|
Serologic Tests | 1 | 1990 | 34 | 0.010 |
Why?
|
Disease Progression | 1 | 1995 | 1120 | 0.010 |
Why?
|
Health Education | 1 | 1992 | 182 | 0.010 |
Why?
|
Phenotype | 1 | 1994 | 1134 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1992 | 400 | 0.010 |
Why?
|
Antigens, CD | 1 | 1991 | 341 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 1991 | 162 | 0.010 |
Why?
|
Polymers | 1 | 1993 | 315 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1989 | 98 | 0.000 |
Why?
|
Binding, Competitive | 1 | 1989 | 97 | 0.000 |
Why?
|
Patient Care Team | 1 | 1992 | 325 | 0.000 |
Why?
|
Freeze Drying | 1 | 1988 | 15 | 0.000 |
Why?
|
Self Administration | 1 | 1988 | 46 | 0.000 |
Why?
|
Incidence | 1 | 1992 | 1226 | 0.000 |
Why?
|
Blood Cells | 1 | 1987 | 16 | 0.000 |
Why?
|
Killer Cells, Natural | 1 | 1989 | 214 | 0.000 |
Why?
|
Pilot Projects | 1 | 1991 | 913 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1991 | 1281 | 0.000 |
Why?
|
Neoplasms | 1 | 1996 | 1239 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 1989 | 548 | 0.000 |
Why?
|
Hepatitis delta Antigens | 1 | 1985 | 2 | 0.000 |
Why?
|
Homosexuality | 1 | 1985 | 6 | 0.000 |
Why?
|
Afghanistan | 1 | 1985 | 11 | 0.000 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1985 | 17 | 0.000 |
Why?
|
Retroviridae Infections | 1 | 1985 | 12 | 0.000 |
Why?
|
Epidemiologic Methods | 1 | 1985 | 64 | 0.000 |
Why?
|
Fibrinogen | 1 | 1985 | 31 | 0.000 |
Why?
|
Molecular Weight | 1 | 1984 | 183 | 0.000 |
Why?
|
Hepatitis B virus | 1 | 1984 | 13 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1987 | 2088 | 0.000 |
Why?
|
Prisoners | 1 | 1985 | 151 | 0.000 |
Why?
|
Genetic Vectors | 1 | 1989 | 807 | 0.000 |
Why?
|
Phorbol Esters | 1 | 1982 | 4 | 0.000 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 1982 | 5 | 0.000 |
Why?
|
Peroxides | 1 | 1982 | 11 | 0.000 |
Why?
|
Neuraminidase | 1 | 1982 | 43 | 0.000 |
Why?
|
Carrier Proteins | 1 | 1982 | 696 | 0.000 |
Why?
|